Current HIV News

 

 HAG: HIV and Aging Group on Facebook®: Tx of Syphilis in HIV+ (Oct 23, 2009)

HAG: HIV and Aging Group on Facebook®: Questions to ask the Dr about arthritis (Oct 23, 2009)

 

HIV treatment may induce protective immunity in brain, monkey study finds (Sep 17, 2009)

 

ICAAC: Phase 2a Study of PRO 140 in HIV-Infected Adults (SEP 17, 2009)

 

HIV titles to link to attached pdfs

 

ICAAC: Effect of Food on Pharmacokinetics of Elvitegravir (SEP 15, 2009)

 

ICAAC: Discovery of GS-9350: A Novel Pharmacoenhancer without Anti-HIV Activity (SEP 15, 2009)

 

ICAAC: Lipds: Maraviroc or Efavirenz? (SEP 15, 2009)

 

ICAAC: Pharmacokinetic boosting of atazanavir with pharmacoenhancer: GS930 vs. Ritonavir (SEP 15, 2009)

 

ICAAC: Vivcriviroc long-term safety and efficacy (SEP 15, 2009)

 

ICAAC: Metabolic profiles and body composition changes in treatment (SEP 15, 2009)

 

ICAAC: GSK’s back-up integrase inhibitor looks good (SEP 15, 2009)

 

ICAAC: Darunavir concentrations in CNS (SEP 15, 2009)

 

ICAAC: Gilead protease inhibitor booster (SEP 15, 2009)

 

ICAAC: Discovery of GS-9350: a novel pharmacoenhancer (SEP 15, 2009)

 

ICAAC: HIV and Aging (SEP 12,2009)

 

People with HIV have a 21yr reduction in life expectancy in the US (June 8, 2009)

New antibodies that neutralize a wide array of HIV types (June 8, 2009)

Tool to offer fast help for HIV exposure (June 8, 2009)

Reassurance that patients with good CD4 cell counts not at risk of HIV-related brain impairment (Aug 27, 2009)

 Recovery of Functional Immunity over 48 Weeks with Darunavir-based Therapy in the GRACE Immunology Substudy  (Jul 21, 2009)

 

 GRACE: New HIV Study Shows that Large Numbers of Women and People of Color can be Successfully Enrolled in U.S. HIV Clinical Studies (Jul 21, 2009)

 African-American Women Need Services is Highlighted in: GRACE (Gender, Race And Clinical Experience): 48-Week Results of Darunavir/r-based Therapy in the Largest Trial in North America to Focus on Treatment-experienced Women  (Jul,21, 2009)

 Differences in Virologic Response Among African Americans and Females Regardless of Therapy in the HEAT Study: African-Americans Have Lower Viral Response Rates

 (Jul 21, 2009)

 

FDA Approves Expanded Use Of HIV Drug (Jul 9, 2009)

 

Police arrest 26 AIDS activists at Capitol protest (Jul 9, 2009)

 

Youth Who Believe They Will Die Young More Likely To Be Diagnosed With HIV/AIDS, Study Finds (Jun 29, 2009)

 

Patients returning after interrupting HIV care have a high risk of short-term illness and death (Jun 29, 2009)

 

National HIV/AIDS Atlas Maps the U.S. Epidemic (Jun 25, 2009)                 

The 5th International AIDS Society Conference (AIDS 2009) Will Take place July 19-22, 2009 in Cape Town, South Africa (Jun 23, 2009)

Alcohol Consumption May Impair Response to HAART and Increase Risk of Liver Toxicity (Jun 23, 2009)

FDA Approves Didanosine (Videx) Label Changes Including Dosage Adjustments and Ribavirin Interaction Warning (Jun 21, 2009)

 

Dangers of Late HIV Testing (Jun 26, 2009)

 

NATIONAL HIV TESTING DAY JUNE 27, 2009 (Jun 26, 2009)

 

Inflammation test can predict heart attacks in people with HIV (Jun 17,2009)   

 

Psoriasis Linked to Vascular Disease (Jun 16,2009)    

 

HIV can cause vascular damage soon after infection (Jun 15,2009)    

 

PSA campaign to try to end HIV/AIDS Stigma in NC (June 3, 2009)

 

Chicago Study Looks at HIV Among Gay Men, Finds Many Unaware of Status  (June 3, 2009)

 

Washington, D.C. Officials To Boost HIV Awareness Efforts (June 2, 2009)

 

Sexual problems common in HIV-positive Gay men (May 14, 2009)

 

HIV treatment does not increase the risk of fractures (May 7, 2009)

 

$10.4B Increase in NIH Funding Could Increase HIV/AIDS Research, Bloomberg Reports (May 7, 2009)

Scientists Receive Grant To Develop Hand-Held Self-Monitoring Test for HIV Viral Loads (May 7, 2009)

 

Swine flu and HIV: guidance issued by US health authorities (May 1, 2009)

 

Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States (Apr 28, 2009)

 

NPR Program Examines Impact of MACS HIV Study Over Past 25 Years (Apr 28, 2009)

Increasing Number of New HIV Cases in El Paso, Texas, Recorded Among Young People (Apr 28, 2009)

 

Act Against AIDS Campaign (Apr 14, 2009)

 

Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents CDC, NIH, and HIV Medicine Association of the IDSA (Apr 10, 2009)

 

Mental impairment relatively more common in younger people with HIV: brain changes seen but significance unclear (Apr 6, 2009)

 

Prevention for HIV serodiscordant couples: it's more than just condoms (Apr 2, 2009)

 

Neurologic Complications of HIV Disease and Their Treatment  (Mar 19, 2009)

 

High rate of anal HPV infection, low rate of clearance and significant new infections in HIV-positive gay men (Mar 17, 2009)

 

Conference highlights the forces encouraging risk behavior in gay men  (Mar 13, 2009)

 

Officials Launch HIV Testing Campaign in Washington, D.C (Mar 19, 2009)

 

HIV/AIDS Rate in D.C. Hits 3% (Mar 15, 2009)

 

National Women and Girls HIV/AIDS Awareness Day 2009 (Mar 10, 2009)

New info challenges old ideas about methadone use and protease inhibitors (Mar 8, 2009)

 

            Poorer responses to lipid-lowering drugs in people with HIV (Mar 3, 2009)

 

Unprotected sex between long-term partners with HIV: no evidence for superinfection (Jan 18, 2009)

 

US Latinos have more unfavourable metabolic and body fat changes on HIV drugs (Jan 16, 2009)

 

Mutations associated with virological response to darunavir/ritonavir in HIV-1-infected protease inhibitor-experienced patients (Jan 15, 2009)

Gilead aiming to put four HIV drugs in one pill (Jan 14, 2009)

 

Improved Measures of Quality of Life, Lipid Profile, and Lipoatrophy After Treatment Interruption in HIV-Infected Patients With Immune Preservation (Jan 8, 2009)

 

New 75 mg Prezista tablet and corresponding pediatric dosing information approved - (Jan 6, 2009)

 

Ziagen 300 mg scored tablet facilitates pediatric treatment of infection with HIV - (Jan 6, 2009)

 

Study: Smoking ban leads to major drop in heart attacks (Jan 5, 2009)

 

Inflammatory cytokines may contribute to endothelial dysfunction in people with untreated HIV (Jan 2, 2009)

 

CD4 cell counts may not be accurate marker of treatment failure for resource-poor HIV care (Dec 23, 2008)

 

Study finds smaller CD4 response to successful antiretroviral therapy following treatment interruptions (Dec 29, 2008)

 

Ventura County, Calif., Effort Seeks To Encourage Hispanics To Talk Openly About HIV/AIDS (Nov 24, 2008)

 

Slow progress to expand routine HIV testing in the US (Nov 21, 2008)

 

Merck's Antiretroviral Isentress More Efficient in Suppressing HIV Among Untreated Patients (Oct 28, 2008)

 

Experimental HIV Maturation Inhibitor Bevirimat Demonstrates Good Antiviral Activity and Favorable Safety Profile (Nov 4, 2008)

 

New Updates to Adult and Adolescent Anti-HIV Treatment Guidelines (Nov 4, 2008)

 

Highlights of ICAAC/IDSA 2008 conference (Oct 27, 2008)

 

Scripps research team sheds light on immune system suppression (Oct 17, 2008)

 

CDC Statement On National Latino AIDS Awareness Day (Oct 16, 2008)

 

Body's Anti-HIV Drug Explained (Oct 13, 2008)

 

CDC report: Male circumcision and Risk for HIV transmission (Accessed Sep 29, 2008)

 

HIV serosorting provides little protection for Gay men (Sep 28, 2008)

 

Circumcision bottoms out (Accessed Sep 27, 2008)

 

Male circumcision and HIV: A Public Policy Weblog (Sep 25, 2008)

 

HIV: Behavioral Intervention Works To Reduce Risky Behavior (Sep 19, 2008)

 

Fibrosis linked to rapid loss of gut CD4 cells after HIV infection (Sep 5, 2008)

 

Raltegravir may cause temporary worsening of pre-existing depression (Sep 5, 2008)

 

Gay men of all ages remain a priority for HIV prevention in the US (Sep 15, 2008)

 

Herpes drug has direct anti-HIV effect, could offer cheap addition to antiretroviral therapy for developing world (Sep 11, 2008)

 

H.I.V. Is Spreading at Three Times National Rate (Aug 27, 2008)

 

HIV/AIDS Groups Express Concern About Potential for New Antiretroviral Advertising To 'Scare Off' Patients  (Aug 25, 2008)

 

Responding to Darunavir/Etravirine For Patients With Resistance - (Aug 11, 2008)

 

Widespread NRTI and NNRTI resistance seen in Malawian patients failing first-line antiretroviral therapy (Aug 8, 2008)

 

Hispanic HIV/AIDS rates a growing health problem (Jul 22, 2008)

 

Patients receive false positive HIV tests (Jun 22, 2008)

 

Report: HIV takes root in Deep South (Jul 21, 2008)

 

Sex in the Inner City'-African American women and HIV (Jul 20, 2008)

 

Trial for Vaccine Against H.I.V. Is Canceled (Jul 18, 2008)

 

Researchers Claim They've Found HIV Weakness: Scientists focusing on a stretch of amino acids on HIV's envelope protein gp120 (Jul 17, 2008)

 

Duffy Antigen Receptor for Chemokines Mediates trans-Infection of HIV-1 from Red Blood Cells to Target Cells and Affects HIV-AIDS Susceptibility (Jul 16, 2008)

 

Herbal Immunotherapy For Multi-Drug (MDR) And Extensively Drug-Resistant Tuberculosis (XDR-TB) As Well As TB With HIV (Jul 14, 2008)

 

Women Who Use Microbicides, Still Contract HIV Could End Up With Fewer Treatment Options Because Of Resistance, Study Finds (Jul 10, 2008)

 

Approaches To HIV Treatment In Africa And Europe Yield Similar Results  (Jul 10, 2008)

 

Gels to protect women from HIV may help men more (Jul 8, 2008)

 

Public-health and individual approaches to antiretroviral therapy: Township South Africa and Switzerland compared (July 2008)

 

The paradoxical effects of using antiretroviral-based microbicides to control HIV epidemics (May, 2008)

 

What Works To Prevent HIV Among Heterosexual African-Americans? (Jul 1, 2008)

 

Communities Nationwide Recognize National HIV Testing Day; Blacks, Hispanics Encouraged To Participate (Jun 30, 2008)

 

HIV Rising Among Young Gay Men In The US (Jun 27, 2008)

 

Group Releases Federal Policy Recommendations Aimed At Addressing HIV/AIDS Rates Among Hispanics (Jun 26, 2008)

 

Monogram Biosciences Announces Immediate Availability of Enhanced Sensitivity Trofile(TM) HIV Tropism Assay (Jun 5, 2008)

 

New Option for HIV Testing Now Available  (May 29, 2008)

 

Viracept (nelfinavir)  may now be prescribed for pregnant women and new pediatric patients (May 9, 2008)

 

Boosting vaginal health could cut HIV risk (May 1, 2008)

 

Higher CD4 cell counts associated with lower rate of non-HIV-related diseases in patients taking antiretrovirals (April 25, 2008)

 

Clinical monitoring as effective as CD4 count and viral load for deciding when to switch to second-line ART in poor countries (April 25, 2008)

 

Benefit of starting HIV treatment early outweighs the risk of toxicities, SMART study shows (Apr 14, 2008)

 

SMART study reaffirms that HIV replication is harmful, even at CD4 counts above 350 (Apr 14, 2008)

 

Even Failing Treatment Reduces HIV in the Brain (Apr 2, 2008)

 

Lower-Dose Zerit May Improve Some Side Effects (Mar 26, 2008)

 

Genetic Variations Might Be Causing Mutations to HIV, Making It Less Potent, Study Says (Mar 25, 2008)

 

Ban on travelers with HIV into U.S. reviewed: Congress set to debate heavily criticized policy (Mar 26, 2008)

 

FDA update on Prezista (darunavir) “Information for Healthcare Professionals” (Mar 21, 2008)

 

FDA 101: Medication Errors (Mar 10, 2008)

 

Decreasing undiagnosed HIV infection helped reduce rate of HIV transmission in US (Mar 12, 2008)

 

Vaccination for pneumococcal pneumonia effective in HIV-positive men (Mar 11, 2008)

 

Fish Oil and Fenofibrate an Effective Combo for High Triglycerides (Mar 11, 2008)

 

Test for Abacavir Hypersensitivity Works in Black and White Patients(Mar 11, 2008)

 

Repeatedly HIV-negative patients with very advanced HIV disease: only 16 cases ever reported (Mar 10, 2008)

 

Genetically Reprogrammed Cells Could Battle HIV  (Mar 7, 2008)

 

Neuropathy Pain Patch Fails Test  (Mar 6, 2008)

 

Faith-Based Organizations Express Support for Needle-Exchange Programs (Mar 5, 2008)

 

Microbicides 2008: Will adherence issues affect all the first-generation trials? (Mar 3, 2008)

 

Microbicides 2008: Microbicides might benefit men more than women (Mar 1, 2008)

 

HIV Treatment Increases Survival, Not Heart Attack Risk (Feb 29, 2008)

 

New 600 mg Darunavir (Prezista) Formulation Allows for Fewer Pills per Dose (Feb 29, 2008)

 

New Approach Stops HIV At Earliest Stage Of Infection  (Feb 28, 2008)

 

Microbicides 2008: the second generation is on its way (Feb 28, 2008)

 

Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection (Feb 28, 2008)

 

VIDEO: Condom-Free Sex? Controversial Swiss Declaration (Feb 12, 2008)

Alone in a City’s AIDS Battle, Hoping for Backup (May 28, 2007)

GeoVax Vaccine Only 5th AIDS Vaccine Moving To Phase 2 Human Trials (Feb 26, 2008)

 

New Prezista 600 mg Tablet Approved (Feb 26, 2008)

 

Microbicides 2008: Accurate adherence reporting essential for microbicide trials (Feb 26, 2008)

 

Microbicides 2008: First hint of efficacy in rectal microbicide trial, thanks to new biopsy assay (Feb 25, 2008)

 

HIV persists in gut CD4 cells even in the presence of effective therapy Feb 25, 2008)

 

Drug Use Linked to Infection With Resistant Virus (Feb 21, 2008)

 

Study Links Zerit and Retrovir With Diabetes Risk (Feb 21, 2008

 

Dipstick Kidney Test Less Accurate in HIV (Feb 20, 2008)

 

UNAIDS & WHO 'Correct' Swiss on Unprotected Sex (Feb 1, 2008)

 

Politics and Policy | FDA To Require Vaginal Contraceptives Containing Nonoxynol-9 To Include Warning Label That Products Do Not Protect Against STIs, Including HIV (Dec 19, 2007)

 

Tests of Drug to Block H.I.V. Infection Are Halted Over Safety (Feb 1, 2007)

 

Microbicide Trials Halted in Africa, India Because of Possible Increased Risk of HIV Transmission (Feb 1, 2007)

 

Follow HIV testing guidelines to avoid false positive diagnosis (Feb 22, 2008)

 

GSK To Reduce Cost of 14 Antiretrovirals Sold in Developing Nations (Feb 20, 2008)

 

CROI: Once-daily Lopinavir/ritonavir (Kaletra) and Nevirapine (Viramune) Appear as Effective as Twice-daily (Feb 19, 2008)

 

GSK cuts the price of one of its most popular nukes, Ziagen (abacavir) ,by 31% for developing countries  (Feb 20, 2008)

 

CROI: Untreated HIV-positive individuals have a higher risk of death even at CD4 counts over 350 (Feb 7, 2008)

 

CROI: Herpes virus suppression with valaciclovir lowers viral load in HIV positive women: could work for gay men too (Feb 7, 2008)

 

CROI: Could earlier ART reduce risk of death from non-AIDS related illnesses in people with HIV? (Feb 6, 2008)

 

Controversy Over Swiss Statement on Safe Sex Without Condoms (Feb 2, 2008)

 

Swiss experts say individuals with undetectable viral load and no STI cannot transmit HIV during sex (Jan 30, 2007)

 

Factors affecting HIV therapy choice in women have changed  (Jan 23, 2008)

 

Emergence of Multidrug-Resistant, Community-Associated, Methicillin-Resistant Staphylococcus aureus Clone USA300 in Men Who Have Sex with Men

(from Annals of Internal Medicine Feb 2008 issue)

 

The Insure Thing (article about HIV positive young adults getting insurance in the Jan 2008 issue of POZ magazine)

 

FDA Approves INtELENCE(tM) (etravirine) for HIV Combination therapy; - INtELENCE is the first NNRtI to show antiviral activity in patients with NNRtI-resistant virus (Jan 22, 2008)

 

Groups Respond to Research That Links Drug-Resistant MRSA Strain to MSM Communities in Boston, San Francisco (Jan 22, 2008)

 

Atazanavir (Reyataz) Label Changes Cover Drug Interactions, Kidney Impairment (Jan 18, 2008)

 

New multi-drug resistant MRSA strain disproportionately affecting gay, HIV-positive men (Jan 15, 2008)

 

Continuing anti-HIV therapy reduces the risk of AIDS-defining events in patients with uncontrolled viral replication and severe immune suppression (Jan 11, 2008)

 

More Heart and Kidney Problems in Treated African Americans (Jan 10, 2008)

 

Most gays ruled out as organ donors: Health Canada ban goes too far to guard against HIV, doctors say (Jan 09, 2008) 

 

Updated guide shows which countries restrict entry and residence for people with HIV (Jan 7, 2008)

 

New York City's Death Rate Reaches Record Low in 2006 in Part Because of Decreased AIDS-Related Deaths (Jan 10, 2008)

 

Spanish find low prevalence of peripheral arterial disease in HIV-positive patients with heart disease risks (Jan 9, 2008)

 

High prevalence of asymptomatic heart disease in HIV-positive patients (Jan 9, 2008)

 

HIV/AIDS Experts, Doctors Voice Concerns About Health Problems Seen Among Long-Term HIV/AIDS Survivors (Jan 8, 2008)

 

HIV-Positive People With Depression More Likely to Follow Treatment Regimens When Taking SSRIs, Study Finds (Jan 8, 2008)

 

Book Examines Experiences of Children With HIV/AIDS, Addresses Treatment, Care, Support Issues (Jan 8, 2008)

 

AIDS patients face downside of living longer New York Times (Jan 6, 2008)

 

Injection drug use, low baseline CD4 counts continue to predict poorer HAART response after six years (Jan 2, 2008)

 

HIV Rates Up Among NY Gays Under 30  (Jan 1, 2008)

 

HIV-Infected Adults With a CD4 Cell Count Greater Than 500 Cells/mm3 on Long-Term HAART Reach Same Mortality Rates as the General Population – (Dec 27, 2007)
 

Darunavir Full Approval & For Naives: Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration - (Dec 21, 2007) 

 

Ingredient in human semen may enhance HIV infection (Dec 13, 2007)

 

Dietary Cod Protein Improves Insulin Sensitivity in Insulin-Resistant Men and Women (Nov 26, 2007)

 

Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV  (Nov 26, 2007)

 

AIDS Cases Drop, but Bad Data to Blame (Nov 20, 2007) 

 

Study shows how some AIDS vaccines may harm  (Nov 16, 2007)

 

Reuters AlertNet: Study shows how some AIDS vaccines may harm (Nov 15, 2007)

 

Lin, et al study: Recombinant adeno-associated virus vectors induce functionally impaired transgene product–specific CD8⁺ T cells in mice (Nov 15, 2007)

 

AASLD: Tibotec HCV Protease Inhibitor  (Nov 9, 2007)

 

Seattle Post-Intelligencer Examines Reactions of People Who Participated in Merck's Canceled HIV Vaccine Trial (Nov 9, 2007)

 

 Former Chair of Presidential Advisory Council on HIV/AIDS Hitt Dies (Nov 9, 2007)

 

HIV/AIDS Researchers Warn South African HIV Vaccine Trial Volunteers About Possible Increased Risk of HIV (Oct 25, 2007)

 

Catholic Church's Opposition to Condom Use Contributes to Spread of HIV in Latin America, UNAIDS Official Says (Oct 24, 2007)

 

Variation in HIV-1 set-point viral load: Epidemiological analysis and an evolutionary hypothesis (Oct 22, 2007)

 

Undetectable viral load is goal for all, together with earlier treatment, say new European treatment guidelines (Oct 25, 2007)

 

EACS: Cocaine Boosts Cardiovascular Risk in Spanish Patients With HIV  (Oct 25, 2007)

 

Scientists Track Progression of HIV to AIDS, Study Says (Oct 19, 2007)

 

Fosamprenavir: US approves once-daily dose with less ritonavir boosting (Oct 19, 2007)

 

FDA Approves Integrase Inhibitor, Raltegavir  (Oct 12, 2007)

 

Protein in spinal fluid can be a marker of HIV dementia (Oct 9, 2007)

 

Archived HIV News

 

Seven pharma firms join forces to identify patients at risk of adverse events (Sep 28, 2007)

 

Intermittent ART Raises Risk for AIDS-Associated Malignancy (Sep 24, 2007)

 

T-20 increases tipranavir levels but does not increase risk of liver side-effects (Sep 12, 2007)

 

Caution Regarding Nelfinavir Use in Children and Pregnant Women (Sep 10, 2007)

 

ICAAC: No drug interactions found between TMC125 and ritonavir-boosted elvitegravir (Sep 21, 2007)

 

ICAAC: Maraviroc failures associated with shifts from R5-tropic to mixed or X4-tropic HIV (Sep 20, 2007)

 

 ICAAC: 48-week results show maraviroc still potent in highly treatment-experienced (Sep 20, 2007)

 

 ICAAC: Dual/mixed tropic virus speeds disease progression as much as tenfold increase in viral load (Sep 19, 2007)

 

Raltegravir Approval Expected in October (Sep 06, 2007)

Merck & Co's AIDS drug Isentress is backed by FDA panel (Sep 06, 2007)
 

Heavy Drinkers living with HIV have lower CD4 counts  (Aug 31 2007)

 

Abbott warns on risk of overdose with Kaletra liquid (Aug 15, 2007)

 

SelzentryTM (Maraviroc) Tablets, CCR5 Inhibitor, Approved by FDA (Jul 27, 2007)

 

IAS: Pendulum swinging towards early treatment as burden of pre-AIDS illness recognised (Jul 27, 2007)

 

IAS: Truvada more effective than Ziagen due to drop-outs related to abacavir hypersensitivity (Jul 26, 2007)

 

IAS: Roche admits long-standing low-level contamination of nelfinavir (Jul 26, 2007)

 

IAS: Screening for B*5701 reduces abacavir hypersensitivity incidence to zero (Jul 25, 2007)

 

International AIDS Conference To Begin in Australia; More Than 5,000 Researchers To Discuss HIV/AIDS Treatment, Prevention Advances (Jul 20, 2007)

A Genetic Knack for Tackling HIV  (Jul 20 2007)

 

9th Intl Wrkshp on Adverse Drug Reactions and Lipo:

Effects of 4 weeks of atazanavir, lopinavir/ritonavir, or placebo on endothelial function and insulin sensitivity in healthy men (Jul 20 2007)

 

9th Intl Wrkshp on Adverse Drug Reactions and Lipo:

Relationship of body composition, antiretroviral use, and HIV disease factors to endothelial dysfunction in HIV-infected subjects: lipoatrophy associated with endothelial dysfunction (Jul 20, 2007)

 

IAS: 'HIV eradication now possible'  (Jul 20, 2007)

 

PFIZER RECEIVES APPROVABLE LETTER FROM FDA FOR MARAVIROC  (Jul 20, 2007)

 

Abbott Submits E.U. and U.S. Regulatory Filings for New Lower-Strength Kaletra and Aluvia (lopinavir/ritonavir) Tablet Suitable for Pediatric Use in HIV/AIDS  (Jul 20, 2007)

 

9th Intl Wrkshp on Adverse Drug Reactions and Lipo:

Lack of evidence of Metabolic Abnormalities and Mitochondrial Toxicity with Enfuvertide: a double-blind, placebo-controlled, cross-over study with random sequence assignation in healthy adult volunteers  (Jul 20, 2007)

 

9th Intl Wrkshp on Adverse Drug Reactions and Lipo: HIV, ART & Endothelial Dysfunction  (Jul 20, 2007)

 

The pre-IAS 2007 themed issue of The Lancet is available online (Jul 9, 2007)

 

 

 

 

Tibotec Announces U.S. Expanded Access Program for TMC114

 

Safety review board gives go-ahead for studies into Pfizer's CCR5 inhibitor to continue as planned

 

Scans show specific patterns of brain damage in patients with AIDS

 

Atazanavir does not lower or raise methadone levels in patients chronically treated for opiate addiction

http://www.medscape.com/viewarticle/514015?src=hp14.infocus

 

Safety of EPZICOM (Abacavir + Lamivudine)-based HAART in ART-naïve HIV Positive Subjects with and without Hepatitis B and/or Hepatitis C Coinfection

 

Safety of LEXIVA (Fosamprenavir/Ritonavir)-containing Regimen Over 120 Weeks in HIV Positive Treatment-naïve Adults with or without hepatitis B and/or C Coinfection

 

Efavirenz detectable in plasma 8 weeks after stopping therapy and subsequent development of non-nucleoside reverse transcriptase inhibitor-associated resistance

 

HIV alters immune response in lungs

 

Dietary supplements cause severe liver inflammation in HIV-positive man

 

High rate of virological failure with didanosine and tenofovir in treatment-experienced patients

 

Wasting in HIV-positive drug users linked to food insecurity and viral load

 

Tipranavir & TDM

Once-Daily vs.Twice-Daily Lopinavir/ritonavir in Antiretroviral-Naive Patients: 96-Week Results
New Gas-Powered T20 Injection Device: 48 week study

Contact us:  edu@freehivinfo.com